Showing 1 - 10 results of 10 for search 'Yasuhiro Funahashi', query time: 0.05s Refine Results
  1. 1
    Dichlorido[6,8,22,24,34,36-hexamethyl-33,35-diaza-3,11,19,27-tetraazoniapentacyclo[27.3.1.15,9.113,17.121,25]hexatriaconta-1(33),5,7,9(34),13,15,17(35),21,23,25(36),29,31-dodecaene-κ6N3,N11,N19,N27,N33,N35]dipalladium(II) bis(perchlorate) N,N-dimethylformamide disolvate methanol disolvate

    Dichlorido[6,8,22,24,34,36-hexamethyl-33,35-diaza-3,11,19,27-tetraazoniapentacyclo[27.3.1.15,9.113,17.121,25]hexatriaconta-1(33),5,7,9(34),13,15,17(35),21,23,25(36),29,31-dodecaene... by Kohei Oda, Yasuhiro Funahashi, Hideki Masuda

    Published 2013-09-01
    Get full text
    Article
  2. 2
    Gene expression profiling reveals epithelial mesenchymal transition (EMT) genes can selectively differentiate eribulin sensitive breast cancer cells.

    Gene expression profiling reveals epithelial mesenchymal transition (EMT) genes can selectively differentiate eribulin sensitive breast cancer cells. by Zoltán Dezső, Judith Oestreicher, Amy Weaver, Stephanie Santiago, Sergei Agoulnik, Jesse Chow, Yoshiya Oda, Yasuhiro Funahashi

    Published 2014-01-01
    Get full text
    Article
  3. 3
    Behavioral analysis in mice deficient for GAREM2 (Grb2-associated regulator of Erk/MAPK subtype2) that is a subtype of highly expressing in the brain

    Behavioral analysis in mice deficient for GAREM2 (Grb2-associated regulator of Erk/MAPK subtype2) that is a subtype of highly expressing in the brain by Tasuku Nishino, Kota Tamada, Akane Maeda, Takaya Abe, Hiroshi Kiyonari, Yasuhiro Funahashi, Kozo Kaibuchi, Toru Takumi, Hiroaki Konishi

    Published 2019-11-01
    Get full text
    Article
  4. 4
    Preparations of <i>trans</i>- and <i>cis</i>-<i>μ</i>-1,2-Peroxodiiron(III) Complexes

    Preparations of <i>trans</i>- and <i>cis</i>-<i>μ</i>-1,2-Peroxodiiron(III) Complexes by Yuji Kajita, Masaki Kubo, Hidekazu Arii, Shinya Ishikawa, Yamato Saito, Yuko Wasada-Tsutsui, Yasuhiro Funahashi, Tomohiro Ozawa, Hideki Masuda

    Published 2023-12-01
    Get full text
    Article
  5. 5
    KANPHOS: Kinase-associated neural phospho-signaling database for data-driven research

    KANPHOS: Kinase-associated neural phospho-signaling database for data-driven research by Takayuki Kannon, Takayuki Kannon, Satoshi Murashige, Tomoki Nishioka, Mutsuki Amano, Yasuhiro Funahashi, Daisuke Tsuboi, Yukie Yamahashi, Taku Nagai, Kozo Kaibuchi, Junichiro Yoshimoto, Junichiro Yoshimoto

    Published 2024-04-01
    Get full text
    Article
  6. 6
    Population pharmacokinetic‐pharmacodynamic modeling of serum biomarkers as predictors of tumor dynamics following lenvatinib treatment in patients with radioiodine‐refractory differentiated thyroid cancer (RR‐DTC)

    Population pharmacokinetic‐pharmacodynamic modeling of serum biomarkers as predictors of tumor dynamics following lenvatinib treatment in patients with radioiodine‐refractory diffe... by Oneeb Majid, Seiichi Hayato, Sree Harsha Sreerama Reddy, Bojan Lalovic, Taro Hihara, Taisuke Hoshi, Yasuhiro Funahashi, Jagadeesh Aluri, Osamu Takenaka, Sanae Yasuda, Ziad Hussein

    Published 2024-06-01
    Get full text
    Article
  7. 7
    KANPHOS: A Database of Kinase-Associated Neural Protein Phosphorylation in the Brain

    KANPHOS: A Database of Kinase-Associated Neural Protein Phosphorylation in the Brain by Rijwan Uddin Ahammad, Tomoki Nishioka, Junichiro Yoshimoto, Takayuki Kannon, Mutsuki Amano, Yasuhiro Funahashi, Daisuke Tsuboi, Md. Omar Faruk, Yukie Yamahashi, Kiyofumi Yamada, Taku Nagai, Kozo Kaibuchi

    Published 2021-12-01
    Get full text
    Article
  8. 8
    Striatal TRPV1 activation by acetaminophen ameliorates dopamine D2 receptor antagonist–induced orofacial dyskinesia

    Striatal TRPV1 activation by acetaminophen ameliorates dopamine D2 receptor antagonist–induced orofacial dyskinesia by Koki Nagaoka, Takuya Nagashima, Nozomi Asaoka, Hiroki Yamamoto, Chihiro Toda, Gen Kayanuma, Soni Siswanto, Yasuhiro Funahashi, Keisuke Kuroda, Kozo Kaibuchi, Yasuo Mori, Kazuki Nagayasu, Hisashi Shirakawa, Shuji Kaneko

    Published 2021-05-01
    Get full text
    Article
  9. 9
    Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway.

    Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway. by Yu Kato, Kimiyo Tabata, Takayuki Kimura, Ayako Yachie-Kinoshita, Yoichi Ozawa, Kazuhiko Yamada, Junichi Ito, Sho Tachino, Yusaku Hori, Masahiro Matsuki, Yukiko Matsuoka, Samik Ghosh, Hiroaki Kitano, Kenichi Nomoto, Junji Matsui, Yasuhiro Funahashi

    Published 2019-01-01
    Get full text
    Article
  10. 10
    Phosphorylation of Npas4 by MAPK Regulates Reward-Related Gene Expression and Behaviors

    Phosphorylation of Npas4 by MAPK Regulates Reward-Related Gene Expression and Behaviors by Yasuhiro Funahashi, Anthony Ariza, Ryosuke Emi, Yifan Xu, Wei Shan, Ko Suzuki, Sachi Kozawa, Rijwan Uddin Ahammad, Mengya Wu, Tetsuya Takano, Yoshimitsu Yura, Keisuke Kuroda, Taku Nagai, Mutsuki Amano, Kiyofumi Yamada, Kozo Kaibuchi

    Published 2019-12-01
    Get full text
    Article

Search Tools: